Impact on management of new diagnostic tests in Alzheimer's disease [7]

Lancet

Volumn 348, Issue 9032, 1996, Pages 961-

  Van Gool, W A ^a   Van Crevel, H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; CAREGIVER; CEREBROSPINAL FLUID ANALYSIS; COUNSELING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENOTYPE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUPIL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029780516     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65373-1     Document Type: Letter

References (3)

1. SG Pauker JP Kassirer Therapeutic decision making: a cost—benefit analysis N Engl J Med 293 1975 229 234
2. J Corey-Bloom LJ Thal D Galasko Diagnosis and evaluation of dementia Neurology 45 1995 211 218
3. DL Kent EB Larson Disease, level of impact, and quality of research methods: three dimensions of clinical efficacy assessment applied to magnetic resonance imaging Invest Radiol 27 1992 245 254